Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Depreciation & Amortization (CF) (2020 - 2025)

Celularity (CELU) has disclosed Depreciation & Amortization (CF) for 6 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 3.7% to $1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $7.4 million, a 11.68% decrease, with the full-year FY2024 number at $7.9 million, down 15.04% from a year prior.
  • Depreciation & Amortization (CF) was $1.8 million for Q3 2025 at Celularity, down from $1.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.6 million in Q4 2021 to a low of $1.8 million in Q3 2025.
  • A 5-year average of $2.2 million and a median of $2.3 million in 2022 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): surged 55.03% in 2021, then decreased 19.16% in 2024.
  • Celularity's Depreciation & Amortization (CF) stood at $2.6 million in 2021, then dropped by 6.41% to $2.4 million in 2022, then fell by 5.86% to $2.3 million in 2023, then decreased by 18.29% to $1.9 million in 2024, then decreased by 2.77% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Depreciation & Amortization (CF) are $1.8 million (Q3 2025), $1.8 million (Q2 2025), and $1.8 million (Q1 2025).